Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Skin Neoplasms

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Skin Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chollet, P; D'Incan, M; Durando, X; Madelmont, JC; Sinsard, A; Thivat, E1
Adenis, A; Chauvergne, J; Chevallier, B; Chollet, P; Fargeot, P; Fumoleau, P; Kerbrat, P; Lentz, MA; Roche, H; Urosevic, V1

Trials

1 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Skin Neoplasms

ArticleYear
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Skin Neoplasms

1996

Other Studies

1 other study(ies) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Skin Neoplasms

ArticleYear
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
    BMC cancer, 2005, Nov-15, Volume: 5

    Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome

2005